GSK-1264
GSK-1264 is an HIV-1 integrase inhibitor. GSK-1264 binds to a site spanning the HIV-1 integrase catalytic core domain and C-terminal domain, mediates formation of an open polymer of HIV-1 integrase dimers via inhibitor-bridged contacts between adjacent dimers. GSK-1264 disrupts late-stage HIV replication by interfering with viral particle assembly. GSK-1264 stimulates inappropriate polymerization of HIV-1 integrase. GSK-1264 can be used for the research of HIV infection.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1392118-63-6
- 分子式: C26H28FNO5
- 分子量:453.50
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
GSK1264 (100-1000 nM; 96 h) potently disrupts formation of mature HIV-1 particles in chronically infected A1953 cells, significantly reducing the percentage of mature virions and increasing deformed particles[1].
GSK1264 (0.5-1.0 mM) binds to a bipartite interface formed by the CTD and CCD of adjacent HIV-1 INY15A,D185A dimers, inducing formation of an open polymer structure at 4.4 Å resolution[1].
GSK1264 (8-10 μM) induces concentration-dependent aggregation of HIV-1 IN fragments containing both CCD and CTD domains in vitro, and this activity requires specific CTD residues at the GSK1264 binding interface[1].
GSK1264 (7 days) inhibits replication of diverse primary HIV-1 isolates in PBMCs with IC50 values of 2-100 μM, and naturally occurring IN polymorphisms can modulate its potency[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 1392118-63-6
-
分子量 453.50
-
分子式 C26H28FNO5
-
SMILES
CC(C)(C)O[C@@H](C1=C(C2=CC(F)=C(OCCC3)C3=C2C)C4=CC=CC=C4C(N1C)=O)C(O)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)